We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx Receives Milestone Payment as Collaborator Receives IND Approval for a Nanobody in Oncology

News   Apr 06, 2012

 
Ablynx Receives Milestone Payment as Collaborator Receives IND Approval for a Nanobody in Oncology
 
 
 

RELATED ARTICLES

Gene Therapy for Life-limiting Blood Disorder Becomes Commercially Available

News

bluebird bio Inc. have announced that their gene therapy for the blood disorder transfusion-dependent β-thalassemia (TDT) is commercially available for the first time.

READ MORE

Diabetes Drug May Help To Prevent Miscarriage

News

According to a new study, an existing drug could be used to improve the womb for pregnancy in those who have had recurrent miscarriages.

READ MORE

Universal Flu Vaccine Protects Against Six Different Influenza Viruses

News

A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE